Literature DB >> 31473802

Risk of undiagnosed coronary artery disease associated with infrapopliteal artery occlusion from a multicenter study.

Shohei Imaeda1, Toshiki Kuno2,3, Keita Hirano4, Masaki Kodaira1, Hitoshi Anzai5, Yohei Numasawa1.   

Abstract

Peripheral artery disease (PAD) is associated with high cardiovascular mortality. Which part of PAD with lower extremities is related to coronary artery disease (CAD) remains unknown. We hypothesized that PAD including infrapopliteal artery (IPA) occlusion was associated with CAD. A total of 260 patients who have no history of CAD or the anginal symptom, complain of the claudication or critical limb ischemia and underwent peripheral angiography were retrospectively analyzed. IPA occlusion was diagnosed with peripheral angiography, and CAD was diagnosed with the coronary angiography. A multivariate logistic regression analysis was performed to determine the predictors of silent CAD. Among them, a total of 146 patients (56.2%) had IPA occlusion. Baseline characteristics were significantly different between two groups as to the proportions of age, male, dyslipidemia (with vs. without IPA occlusion; 72.4 ± 10.8 vs. 69.1 ± 10.2; 62.3% vs. 75.4%; 38.6% vs. 52.6%, respectively, all comparisons P < 0.05). Notably, the prevalence of CAD was significantly higher in patients with IPA occlusion (50.7% vs. 34.2%, P = 0.008). On a multivariate analysis, IPA occlusion was an independent predictor for the presence of silent CAD (OR, 1.94; CI, 1.09-3.44, P = 0.024), but aortoiliac artery occlusion (OR, 1.16; CI, 0.53-2.56, P = 0.71) and femoropopliteal artery occlusion (OR, 1.02; CI, 0.57-1.83, P = 0.96) were not. IPA occlusion was associated with silent CAD. Vascular surgeons, interventional radiologists, as well as interventional cardiologists should recognize IPA occlusion as a risk factor of silent CAD.

Entities:  

Keywords:  Coronary artery disease; Infrapopliteal artery; Peripheral artery disease; Silent ischemia

Mesh:

Year:  2019        PMID: 31473802     DOI: 10.1007/s00380-019-01495-x

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  29 in total

Review 1.  Evidence-based management of PAD & the diabetic foot.

Authors:  J R W Brownrigg; J Apelqvist; K Bakker; N C Schaper; R J Hinchliffe
Journal:  Eur J Vasc Endovasc Surg       Date:  2013-03-27       Impact factor: 7.069

2.  ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography.

Authors:  Manesh R Patel; Gregory J Dehmer; John W Hirshfeld; Peter K Smith; John A Spertus
Journal:  J Am Coll Cardiol       Date:  2012-01-30       Impact factor: 24.094

3.  Clinical characteristics of silent myocardial ischemia diagnosed with adenosine stress 99mTc-tetrofosmin myocardial scintigraphy in Japanese patients with acute cerebral infarction.

Authors:  Tetsuya Nomura; Tetsuro Kusaba; Naotoshi Kodama; Kensuke Terada; Yota Urakabe; Susumu Nishikawa; Natsuya Keira; Hiroaki Matsubara; Tetsuya Tatsumi
Journal:  Heart Vessels       Date:  2011-11-29       Impact factor: 2.037

4.  Management of Critical Limb Ischemia.

Authors:  Scott Kinlay
Journal:  Circ Cardiovasc Interv       Date:  2016-02       Impact factor: 6.546

5.  Prevalence of carotid stenosis and silent myocardial ischemia in asymptomatic subjects with a low ankle-brachial index.

Authors:  Jose M Mostaza; Jose R González-Juanatey; Jose Castillo; Carlos Lahoz; Jose M Fernández-Villaverde; Francisco J Maestro-Saavedra
Journal:  J Vasc Surg       Date:  2008-10-01       Impact factor: 4.268

6.  Prediction of late cardiac events by dipyridamole thallium scintigraphy in patients with intermittent claudication and occult coronary artery disease.

Authors:  D Darbar; N Gillespie; G Main; A B Bridges; N S Kennedy; T H Pringle; G P McNeill
Journal:  Am J Cardiol       Date:  1996-10-01       Impact factor: 2.778

7.  Infrapopliteal drug-eluting stents for chronic limb ischemia.

Authors:  A G Grant; C J White; T J Collins; J S Jenkins; J P Reilly; S R Ramee
Journal:  Catheter Cardiovasc Interv       Date:  2008-01-01       Impact factor: 2.692

8.  Evaluation and management of patients with peripheral artery disease by interventional radiologists: current practices.

Authors:  Ethan A Prince; Timothy P Murphy; Raj Dhangana; Gregory M Soares; Sun H Ahn; Gregory J Dubel
Journal:  J Vasc Interv Radiol       Date:  2008-03-28       Impact factor: 3.464

9.  Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main findings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudy.

Authors:  Michael J Zellweger; Michael Maraun; Hans H Osterhues; Ulrich Keller; Jan Müller-Brand; Raban Jeger; Otmar Pfister; Thilo Burkard; Friedrich Eckstein; Stefanie von Felten; Stefan Osswald; Matthias Pfisterer
Journal:  JACC Cardiovasc Imaging       Date:  2014-09-17

Review 10.  Diagnosis and risk assessment of lower extremity peripheral arterial disease.

Authors:  Omran Abul-Khoudoud
Journal:  J Endovasc Ther       Date:  2006-02       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.